These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9309372)

  • 21. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses.
    Mendling W; Krauss C; Fladung B
    Mycoses; 2004 Apr; 47(3-4):136-42. PubMed ID: 15078430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability of long-term fluconazole therapy.
    Davis MR; Nguyen MH; Donnelley MA; Thompson Iii GR
    J Antimicrob Chemother; 2019 Mar; 74(3):768-771. PubMed ID: 30535104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluconazole dose recommendation in urinary tract infection.
    Boedeker KS; Kilzer WJ
    Ann Pharmacother; 2001 Mar; 35(3):369-72. PubMed ID: 11261537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia.
    Tatetsu H; Asou N; Nakamura M; Hanaoka N; Matsuno F; Horikawa K; Mitsuya H
    Am J Hematol; 2006 May; 81(5):366-9. PubMed ID: 16628725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible acute adrenal insufficiency caused by fluconazole in a critically ill patient.
    Santhana Krishnan SG; Cobbs RK
    Postgrad Med J; 2006 Sep; 82(971):e23. PubMed ID: 16954446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluconazole-carbamazepine interaction in a patient with bipolar disorder.
    Tsouli S; Maranis S; Kyritsis AP
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):112. PubMed ID: 21265947
    [No Abstract]   [Full Text] [Related]  

  • 28. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
    Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of high dosage fluconazole in therapy of candida infections in intensive care medicine].
    Duswald KH; Pittrow L; Penk A
    Anaesthesiol Reanim; 1998; 23(5):134-8. PubMed ID: 9854332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenocortical insufficiency is not a problem in preterm infants treated with antifungal prophylaxis with fluconazole.
    Costa S; Barone G; Vento G; Tirone C; Perelli S; Romagnoli C
    Acta Paediatr; 2014 Jun; 103(6):e234-7. PubMed ID: 24575768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
    Sobel JD; Kapernick PS; Zervos M; Reed BD; Hooton T; Soper D; Nyirjesy P; Heine MW; Willems J; Panzer H; Wittes H
    Am J Obstet Gynecol; 2001 Aug; 185(2):363-9. PubMed ID: 11518893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of fluconazole for the treatment of onychomycosis.
    Brown SJ
    Ann Pharmacother; 2009 Oct; 43(10):1684-91. PubMed ID: 19776299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose fluconazole therapy in Intensive Care Unit.
    De Bellis P; Bonfiglio M; Gerbi G; Bacigalupo P; Buscaglia G; Guido P; Massobrio B
    Minerva Anestesiol; 2003 Mar; 69(3):145-52, 153-57. PubMed ID: 12792583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A brief review of antifungal therapy for deep fungal infection.
    Muller RJ
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
    Fehér J; Lengyel G
    Orv Hetil; 2003 Aug; 144(34):1677-82. PubMed ID: 14528841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis.
    Vandercam B; Gibbs D; Valtonen M; Jäger H; Armignacco O
    J Int Med Res; 1998; 26(4):209-18. PubMed ID: 9818788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alopecia associated with fluconazole therapy.
    Goldsmith LA
    Ann Intern Med; 1996 Jul; 125(2):153; author reply 153-4. PubMed ID: 8678374
    [No Abstract]   [Full Text] [Related]  

  • 39. A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
    Viljoen J; Azie N; Schmitt-Hoffmann AH; Ghannoum M
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1671-9. PubMed ID: 25561337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
    Li T; Zhu Y; Fan S; Liu X; Xu H; Liang Y
    Med Mycol; 2015 Jun; 53(5):455-61. PubMed ID: 25877666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.